Back
Bicycle Therapeutics PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
25
BCYC
Bicycle Therapeutics PLC
Last Price:
23.63
Seasonality Move:
12.97%
Buy
51
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.14
Seasonality Move:
3.75%
Sell
25
Bicycle Therapeutics PLC (BCYC)
is a Sell
Is Bicycle Therapeutics PLC a Buy, Sell or Hold?
- The current Bicycle Therapeutics PLC [BCYC] share price is $23.62. The Score for BCYC is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- BCYC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Adaptimmune Therapeutics PLC (ADAP)
is a Buy
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.14. The Score for ADAP is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ADAP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BCYC Stock Price Chart
What is Bicycle Therapeutics PLC's stock price today?
-
The Bicycle Therapeutics PLC share price today is $23.62
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCYC is experiencing slight selling pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $1.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.
BCYC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 51.8 | Buy |
| Chaikin Money Flow: | -86629 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.26 - 23.84) | Buy |
| Bollinger Bands (100): | (18.26 - 24.54) | Buy |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 46.44 | Sell |
| Chaikin Money Flow: | 937521 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.02 - 1.28) | Sell |
| Bollinger Bands (100): | (0.79 - 1.47) | Buy |
BCYC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.8 | Sell |
| 20-day SMA: | 23.09 | Buy |
| 50-day SMA: | 23.9 | Sell |
| 200-day SMA: | 20.25 | Buy |
| 8-day EMA: | 23.58 | Buy |
| 20-day EMA: | 23.42 | Buy |
| 50-day EMA: | 23.01 | Buy |
| 200-day EMA: | 21.55 | Buy |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.16 | Sell |
| 20-day SMA: | 1.1 | Buy |
| 50-day SMA: | 1.33 | Sell |
| 200-day SMA: | 0.9 | Buy |
| 8-day EMA: | 1.14 | Buy |
| 20-day EMA: | 1.16 | Sell |
| 50-day EMA: | 1.21 | Sell |
| 200-day EMA: | 1.09 | Buy |
Bicycle Therapeutics PLC Earnings Growth & BCYC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.19 per share, an increase next quarter of $0.11 per share, an increase this year of $0.83 per share, and a decrease next year of $0.58 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.08 per share.
Bicycle Therapeutics PLC Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||